PMID: 15374394May 1, 1992Paper

Pharmacokinetics of nimodipine in multimorbid elderly patients with chronic brain failure

Archives of Gerontology and Geriatrics
H EicherE Mutschler

Abstract

Twenty-one elderly patients with chronic brain failure received a single 30 mg oral dose of the calcium channel blocker nimodipine followed by two weeks of 30 mg three times a day (t.i.d.) administration. The aim of this study was to assess if drug accumulation occurred in our frail elderly subjects under this dose regimen. Plasma concentrations of nimodipine and three main metabolites were determined by gas chromatography. During the 2-week period we did not find significant changes in peak plasma concentrations and corresponding areas under the plasma concentration-time curves. Trough nimodipine plasma concentrations before administration of the morning dose were similar on days 7 and 14. Therefore, no evidence of drug accumulation was found. Blood pressure and heart rate remained stable throughout the study period and no adverse effects were observed. During the study period, there was a decline in the proportion of patients who complained about dizziness and insomnia. Overall, our data suggest that there is no need to alter the usual adult dose of nimodipine if this drug is administered to multimorbid frail elderly patients suffering from chronic brain failure.

References

Nov 1, 1990·Clinical Pharmacokinetics·C DurnasB J Cusack
Oct 1, 1989·Clinical Pharmacokinetics·S Dawling, P Crome
Jan 28, 1988·The New England Journal of Medicine·H J GelmersH J Wiezer
May 1, 1986·Statistics in Medicine·W W Hauck, S Anderson
Jan 1, 1986·Therapeutic Drug Monitoring·D J GreenblattR I Shader
Jan 1, 1987·British Journal of Clinical Pharmacology·F M GengoH Bernhard
Jan 1, 1982·European Journal of Drug Metabolism and Pharmacokinetics·G M Pacifici, G F Placidi
Jul 1, 1984·Archives of Gerontology and Geriatrics·D PlattJ Vollmar
Jan 1, 1981·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·A M HarperS Kazda

❮ Previous
Next ❯

Citations

May 3, 2011·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Naoto TanabeTakao Orii
Aug 11, 2006·Journal of Neurophysiology·M H Rowe, E H Peterson
Jul 26, 2002·The Cochrane Database of Systematic Reviews·J M López-Arrieta, J Birks
Jun 24, 2021·Drugs & Aging·Augusto Pietro CasaniSilvia Capobianco

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.